509 Potent and selective inhibition Of AXL receptor tyrosine kinase for the treatment of cancer

• Matthew Walters,
• Yu Chen,
• Stephen Young,
• Akshata Udyavar,
• Sean Cho,
• Susan Paprcka,
• Subhasree Sridhar,
• Dillon Miles,
• Corinne Foley,
• Rebecca Grange,
• Sharon Zhao

Affiliations

Matthew Walters

1Arcus Biosciences Inc, Hayward, CA, USA

Yu Chen

1 Department of Rheumatology and Immunology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China

Stephen Young

1Arcus Biosciences Inc, Hayward, CA, USA

Akshata Udyavar

1Arcus Biosciences Inc, Hayward, CA, USA

Sean Cho

1Arcus Biosciences Inc, Hayward, CA, USA

Susan Paprcka

Arcus Biosciences, Hayward, CA, USA

Subhasree Sridhar

Arcus Biosciences, Hayward, CA, USA

Dillon Miles

Arcus Biosciences, Hayward, CA, USA

Corinne Foley

Arcus Biosciences, Hayward, CA, USA

Rebecca Grange

Arcus Biosciences, Hayward, CA, USA

Sharon Zhao

Arcus Biosciences, Hayward, CA, USA